Teladoc Health (NYSE:TDOC) Stock Jumps 8.1% – What’s Next?

Teladoc Health, Inc. (NYSE:TDOC) rose 8.1% during mid-day trading on Tuesday. The company traded as high as $6.18 and last traded at $6.1950. 1,880,053 shares changed hands during mid-day trading, a decline of 63% from the average daily volume of 5,040,161 shares. The stock had previously closed at $5.73.

Wall Street Analyst Weigh In

TDOC has been the subject of several research analyst reports. Citigroup lowered their price objective on shares of Teladoc Health from $11.00 to $7.50 and set a “neutral” rating for the company in a research report on Monday, August 3rd. Canaccord Genuity Group dropped their price objective on shares of Teladoc Health from $11.00 to $10.00 and set a “buy” rating for the company in a report on Thursday, July 30th. Bank of America lifted their target price on shares of Teladoc Health from $9.00 to $10.50 and gave the stock a “buy” rating in a research report on Tuesday, July 7th. Finally, Weiss Ratings reissued a “sell (d-)” rating on shares of Teladoc Health in a report on Wednesday, August 19th. Five investment analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $7.54.

Teladoc Health Stock Performance

The stock has a market capitalization of $1.15 billion, a price-to-earnings ratio of -6.38 and a beta of 2.14. The company has a fifty day simple moving average of $6.17 and a 200 day simple moving average of $6.90.

Teladoc Health (NYSE:TDOC) last issued its quarterly earnings results on Wednesday, July 29th. The health services provider reported ($0.21) earnings per share for the quarter, beating the consensus estimate of ($0.25) by $0.04. Teladoc Health had a negative return on equity of 12.15% and a negative net margin of 7.13%. The company had revenue of $606.93 million during the quarter, compared to analysts’ expectations of $615.44 million. During the same quarter in the prior year, the firm posted ($0.19) earnings per share. The business’s quarterly revenue was down 4.0% on a year-over-year basis. Teladoc Health has set its Q3 2026 guidance at -0.300–0.200 EPS and its FY 2026 guidance at -1.000–0.750 EPS. As a group, equities analysts predict that Teladoc Health, Inc. will post -0.92 earnings per share for the current fiscal year.

Insider Transactions at Teladoc Health

In other Teladoc Health news, CEO Charles III sold 17,805 shares of the firm’s stock in a transaction that occurred on Friday, September 11th. The shares were sold at an average price of $6.10, for a total transaction of $108,610.50. Following the completion of the transaction, the chief executive officer owned 465,535 shares in the company, valued at approximately $2,839,763.50. This trade represents a 3.68% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders own 0.70% of the company’s stock.

Institutional Investors Weigh In On Teladoc Health

Several large investors have recently modified their holdings of TDOC. VIRGINIA RETIREMENT SYSTEMS ET Al bought a new stake in Teladoc Health in the second quarter worth about $1,447,000. Monaco Asset Management SAM purchased a new stake in shares of Teladoc Health during the 2nd quarter worth approximately $26,864,000. ABS Investment Management LLC purchased a new stake in shares of Teladoc Health during the 2nd quarter worth approximately $1,513,154. ABS Direct Equity Fund LLC bought a new stake in shares of Teladoc Health in the 2nd quarter worth approximately $1,513,000. Finally, Legal & General Group Plc bought a new stake in shares of Teladoc Health in the 2nd quarter worth approximately $1,358,000. 76.82% of the stock is currently owned by institutional investors and hedge funds.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services and technology designed to connect patients with medical professionals remotely. Through its digital platforms, the company supports a range of healthcare needs, including general medical consultations, mental health services, specialty care, and ongoing management of chronic conditions.

Its offerings include telehealth visits with physicians and other licensed providers, behavioral health services through BetterHelp, and chronic care programs that use digital tools and clinical support to help people manage conditions such as diabetes and hypertension.